Arrowhead Pharmaceuticals Aktie
27,57
EUR
-0,09
EUR
-0,33
%
32,37
USD
-0,46
USD
-1,39
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
07.09.18 | Arrowhead Pharmaceuticals Buy | B. Riley FBR | |
06.09.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
08.08.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
02.07.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
09.05.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
10.11.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
19.05.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets |
Werbung
Werbung